Diagnostic-testing stocks drop after proposed Medicare lab payment cuts
Labcorp and Quest Diagnostics shares fell in premarket after CMS proposed cuts to Medicare payment rates for laboratory services.
Shares of diagnostic-testing companies fell after the Centers for Medicare & Medicaid Services proposed cuts to Medicare payment rates for laboratory services. 90 in premarket trading Tuesday.